Literature DB >> 10517293

Membrane potential as a modulator of the free intracellular Ca2+ concentration in agonist-activated endothelial cells.

M Kamouchi1, G Droogmans, B Nilius.   

Abstract

We have used combined patch clamp and fura-2 fluorescence to elucidate the role of membrane potential in the regulation of the cytosolic Ca2+ concentration ([Ca2+]i) in a human umbilical vein derived endothelial cell-line, EA.hy926 (EA cells) stimulated with vasoactive agonists, such as ATP, histamine and bradykinin. This stimulation caused hyperpolarization and sustained Ca2+ plateau in nonclamped cells. Clamping agonist-stimulated cells at negative potentials enhanced the amplitude of this plateau, whereas it was smaller at more depolarized potentials, indicating that Ca2+ influx follows its driving force. Depolarization of the membrane by increasing extracellular K+ or by applying charybdotoxin, a blocker of big conductance Ca2+-dependent K+ channels during agonist stimulation diminished the plateau rise in [Ca2+]i. It is concluded that the membrane potential is an efficient regulator of Ca2+ influx during the plateau phase of agonist-mediated Ca2+ signals. In addition, the modulating effects on Ca2+ signals should be interpreted with caution if the membrane potential of the cells is not controlled.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517293

Source DB:  PubMed          Journal:  Gen Physiol Biophys        ISSN: 0231-5882            Impact factor:   1.512


  24 in total

Review 1.  Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses.

Authors:  Cor de Wit; Tudor M Griffith
Journal:  Pflugers Arch       Date:  2010-04-09       Impact factor: 3.657

Review 2.  Vascular large conductance calcium-activated potassium channels: functional role and therapeutic potential.

Authors:  Birgit Eichhorn; Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-12       Impact factor: 3.000

3.  Openers of SKCa and IKCa channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar vasodilation.

Authors:  Jian-zhong Sheng; Srikanth Ella; Michael J Davis; Michael A Hill; Andrew P Braun
Journal:  FASEB J       Date:  2008-12-12       Impact factor: 5.191

Review 4.  Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?

Authors:  Michel Félétou
Journal:  Br J Pharmacol       Date:  2009-01-29       Impact factor: 8.739

5.  Intracellular Na(+) modulates large conductance Ca(2+)-activated K (+) currents in human umbilical vein endothelial cells.

Authors:  Guo Hua Liang; Moon Young Kim; Seonghee Park; Ji Aee Kim; Shinkyu Choi; Suk Hyo Suh
Journal:  Pflugers Arch       Date:  2008-03-26       Impact factor: 3.657

6.  Smooth muscle membrane potential modulates endothelium-dependent relaxation of rat basilar artery via myo-endothelial gap junctions.

Authors:  Tracy Allen; Mircea Iftinca; William C Cole; Frances Plane
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

7.  Cellular target of voltage and calcium-dependent K(+) channel blockers involved in EDHF-mediated responses in rat superior mesenteric artery.

Authors:  P Ghisdal; N Morel
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

8.  Bioelectric Control of Metastasis in Solid Tumors.

Authors:  Samantha L Payne; Michael Levin; Madeleine J Oudin
Journal:  Bioelectricity       Date:  2019-09-16

9.  Hydrogen sulfide dilates rat mesenteric arteries by activating endothelial large-conductance Ca²⁺-activated K⁺ channels and smooth muscle Ca²⁺ sparks.

Authors:  Olan Jackson-Weaver; Jessica M Osmond; Melissa A Riddle; Jay S Naik; Laura V Gonzalez Bosc; Benjimen R Walker; Nancy L Kanagy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-03-22       Impact factor: 4.733

10.  Oxidized Low-density Lipoprotein- and Lysophosphatidylcholine-induced Ca Mobilization in Human Endothelial Cells.

Authors:  Moon Young Kim; Guo Hua Liang; Ji Aee Kim; Soo Seung Choi; Shinku Choi; Suk Hyo Suh
Journal:  Korean J Physiol Pharmacol       Date:  2009-02-20       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.